CBT for the treatment of depression in Parkinson's disease: A promising nonpharmacological approach

Expert Review of Neurotherapeutics

Volumn 8, Issue 1, 2008, Pages 27-35

  Dobkin, Roseanne DeFronzo ^a   Menza, Matthew ^a   Bienfait, Karina L ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Cognitive behavioral therapy; Depression; Nonpharmacological treatment; Parkinson's disease

Indexed keywords

ARTICLE; CAREGIVER; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DISEASE COURSE; GERIATRIC PATIENT; HUMAN; MENTAL DISEASE; MOTOR DYSFUNCTION; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; QUALITY OF LIFE; SOCIAL SUPPORT; THERAPY EFFECT;

COGNITIVE THERAPY; DEPRESSION; EXPERT TESTIMONY; HUMANS; PARKINSON DISEASE; QUALITY OF LIFE; SOCIAL SUPPORT;

EID: 38149126440     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.8.1.27     Document Type: Article

References (93)

1. Arean PA, Cook BL. Psychotherapy and combined psychotherapy/ pharmacotherapy for late life depression. Biol. Psychiatry 52(3), 293-303 (2002).
2. Floyd M, Scogin F, McKendree-Smith N, Floyd DL, Rokke PD. Cognitive therapy for depression: a comparison of individual psychotherapy and bibliotherapy for depressed older adults. Behav. Modif. 28(2), 297-318 (2004).
3. Mohr DC, Likosky W, Bertagnolli A et al. Telephone-administered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis. J. Consult. Clin. Psychol. 68(2), 356-361 (2000).
4. Allen LA, Woolfolk RL, Gara MA, Escobar JI, Hamer R. Cognitive behavior therapy for somatization disorder. Arch. Intern. Med. 166(14), 1512-1518 (2006). •• A well-designed placebo-controlled study that demonstrates the efficacy of CBT for alleviating psychological distress and improving physical functioning amongst patients with a physically disabling condition.
5. Kunik ME, Braun U, Stanley MA et al. One session cognitive behavioural therapy for elderly patients with chronic obstructive pulmonary disease. Psychol. Med. 31(4), 717-723 (2001).
6. Goldstein LH, McAlpine M, Deale A et al. Cognitive behaviour therapy with adults with intractable epilepsy and psychiatric co-morbidity: preliminary observations on changes in psychological state and seizure frequency. Behav. Res. Ther. 41(4), 447-460 (2003).
7. Butler AC, Chapman JE, Forman EM, Beck AT. The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clin. Psychol. Rev. 26(1), 17-31 (2006).
8. DeRubeis RJ, Crits-Christoph P. Empirically supported individual and group psychological treatment for adult mental disorders. J. Consul. Clin. Psychol. 66(1), 37-52 (1998).
9. Gloaguen V, Cottraux J, Cucherat M, Blackburn IM. A meta-analysis of the effects of cognitive therapy in depressed patients. J. Affect. Disord. 49, 59-72 (1998).
10. Feldman G. Cognitive and behavioral therapies for depression: overview, new directions, and practical recommendations for dissemination. Psychiatr. Clin. N. Am. 30, 39-50 (2007).
11. Keller MB, McCullough JP, Klein DN et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N. Engl. J. Med. 342(20), 1462-1470 (2000).
12. Otto MW, Smits JAJ, Reese HE. Combined psychotherapy and pharmacotherapy for mood and anxiety disorders in adults: review and analysis. Clin. Psychol. Sci. Prac. 12, 72-86 (2005).
13. DeRubeis RJ, Hollon SD, Amsterdam JD et al. Cognitive therapy versus medication in the treatment of moderate to severe depression. Arch. Gen. Psychiatry 62, 409-416 (2005).
14. DeRubeis RJ, Gelfand LA, Tang TZ, Simons AD. Medications versus cognitive therapy for severely depressed outpatients: mega-analysis of four randomized comparisons. Am. J. Psychiatry 156(7), 1007-1013 (1999).
15. Dimidjian S, Hollon SD, Dobson, KS et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J. Consult. Clin. Psychol. 74(4), 658-670 (2006).
16. Hollon SD, DeRubeis RJ, Shelton RC et al. Prevention of relapse following cognitive therapy versus medication in moderate to severe depression. Arch. Gen. Psychiatry 62, 417-422 (2005).
17. Jost WH. Costs in the treatment of parkinsonism. J. Neurol. 247(Suppl. 4), IV/31-33 (2000).
18. Cummings JL. Depression and Parkinson's disease: a review. Am. J. Psychiatry 149, 443-454 (1992).
19. Marsh L, McDonald WM, Cummings J, Ravina B, NINDS/NIMH Work Group on Depression and Parkinson's Disease. Provisional diagnostic criteria for depression in Parkinson's disease: Report of an NINDS/NIMH work group. Mov. Disord. 21(2), 148-158 (2006). •• Paper presents a summary of expert consensus regarding differential diagnosis of depression in Parkinson's disease (dPD). Experts recommend using an inclusive approach in the evaluation and treatment of dPD. Thus, overlapping symptoms should be counted towards a diagnosis of depression, assuming the presence of low mood or loss of interest (necessary criteria for the diagnosis of major depression or dysthymia).
20. Richard IH, Frank S, McDermott MP et al. The ups and downs of Parkinson's disease - a prospective study of mood and anxiety fluctuations. Cog. Behav. Neurol. 17, 201-207 (2004).
21. Menza MA, Sage J, Marshall E et al. Mood changes and "on-off" phenomena in Parkinson's disease. Mov. Disord. 5, 148-151 (1990).
22. Nissembaum H, Quinn NP, Brown RG et al. Mood swings associated with the "on-off" phenomenon in Parkinson's disease. Psychol. Med. 17, 899-904 (1987).
23. Tandberg E, Larsen JP, Aarsland D, Cummings JL. The occurrence of depression in Parkinson's disease: a community-based study. Arch. Neurol. 53, 175-179 (1996).
24. Dooneef G, Mirabello E, Bell K, Marder K, Stern Y, Mayeux R. An estimate of the incidence of depression in idiopathic Parkinson's disease. Arch. Neurol. 49, 305-307 (1992).
25. Allain H, Schuck S, Manduit N. Depression in Parkinson's disease. Br. Med. J. 320(7245), 1287-1288 (2000).
26. Cummings JL, Masternan DL. Depression in patients with Parkinson's disease. Int. J. Geriatr. Psychiatry 14, 711-718 (1999).
27. Cole SA, Woodard JL, Juncos JL et al. Depression and disability in Parkinson's disease. J. Neuropsychiat. Clin. Neurosci. 8, 20-25 (1996).
28. Tandberg E, Larsen JP, Aarsland D et al. Risk factors for depression in Parkinson's disease. Arch. Neurol. 54, 625-639 (1997).
29. Menza MA, Mark MH. Parkinson's disease and depression: the relationship to disability and personality. J. Neuropsychiat. Clin. Neurosci. 6, 165-169 (1994).
30. Shiba M, Bower JH, Maraganore DM et al. Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Mov. Disord. 15(4), 669-677 (2000).
31. Weintraub D, Moberg PJ, Duda JE, Katz IR, Stern MB. Recognition and treatment of depression in Parkinson's disease. J. Geriatr. Psychiatry Neurol. 16, 178-183 (2003).
32. The Global Parkinson's Disease Survey (GPDS) Steering Committee. Factors impacting on quality of life in Parkinson's disease: results from an international survey. Mov. Disord. 17, 60-67 (2002).
33. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 69, 308-312 (2000).
34. Brown RG, MacCarthy B, Gotham AM et al. Depression and disability in Parkinson's disease: a follow-up of 132 cases. Psychol. Med. 18, 49-55 (1988).
35. Starkstein SE, Mayberg HS, Leiguarda R, Preziosi TJ, Robinson RG. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 55, 377-382 (1992).
36. Whetten-Goldstein K, Sloan F, Kulas E, Cutson T, Schenkman M. The burden of Parkinson's disease on society, family, and the individual. J. Am. Geriatr. Soc. 45(7), 844-849 (1997).
37. Klaassen T, Verhey FR, Sneijders GH, de Vet HC, van Praag H. Treatment of depression in Parkinson's disease: a meta-analysis. J. Neuropsych. Clin. Neurosci. 7, 281-286 (1995).
38. Weintraub D, Morales KH, Moberg PJ et al. Antidepressant studies in Parkinson's disease: a review and meta-analysis. Mov. Disord. 20(9), 1161-1169 (2005). •• A meta-analysis that suggests that antidepressants may not be as helpful for treating dPD as they are for geriatric depression.
39. Duvoisin RC, Sage J. Parkinson's Disease: A Guide For Patient And Family (5th Edition). Lippincott Williams & Wilkins, PA, USA (2001).
40. Kalteis K, Standhardt H, Kryspin-Exner I, Brucke T, Volc D, Alesch F. Influence of bilateral Stn-stimulation on psychiatric symptoms and psychosocial functioning in patients with Parkinson's disease. J. Neural Transm. 113, 1191-1206 (2005).
41. Funkiewiez A, Ardouin C, Caputo E et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behavior in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 75, 834-839 (2004).
42. Daniele A, Albanese A, Contarino MF et al. Cognitive and behavioral effects of chronic stimulation of the subthalamic nucleus in patients with Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 74, 175-182 (2003).
43. Berney A, Vingerhoets F, Perrin A et al. Effect on mood of subthalamic DBS for Parkinson's disease: a consecutive series of 24 patients. Neurology 59, 1427-1429 (2002).
44. Voon V, Saint-Cyr JA, Lozano AM, Moro E, Dujardin K, Lang AE. Suicide risk in patients with Parkinson's disease undergoing subthalamic stimulation. Mov. Disord. 19(9), S323 (2004) (Abstract P491).
45. Herzog J, Reiff J, Krack P et al. Manic episode with psychotic symptoms induced by subthalamic nucleus stimulation in a patient with Parkinson's disease. Mov. Disord. 18, 1382-1384 (2003).
46. Kulisevsky J, Berthier ML, Gironell A, Pascual-Sedano B, Molet J, Pares P. Mania following deep brain stimulation for Parkinson's disease. Neurology 59, 1421-1424 (2002).
47. Romito LM, Raja M, Daniele A et al. Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson's disease. Mov. Disord. 17, 1371-1374 (2002).
48. Schmitz-Hubsch T, Pyfer D, Kielwein K, Fimmers R, Klockgether T, Wullner U. Qigong excerice for the symptoms of Parkinson's disease: a randomized, controlled pilot study. Mov. Disord. 21(4), 543-548 (2006).
49. Paus S, Schmitz-Hubsch T, Wallner U, Vogel A, Klockgether T, Abele M. Bright light therapy in Parkinson's disease: a pilot study. Mov. Disord. 22(10), 1495-1498 (2007).
50. Willis GL, Turner EJD. Primary and secondary features of Parkinson's disease improve with strategic exposure to bright light: a case series study. Chronobiol. Int. 24(3), 521-537 (2007).
51. Dreising H, Beckmann J, Wermuth L, Skovlund S, Bech P. Psychological effects of structured cognitive psychotherapy in young patients with Parkinson's disease: a pilot study. Nordic J. Psychiatry 53, 217-221 (1999).
52. Dobkin RD, Allen LA, Menza M. Cognitive behavior therapy for depression in Parkinson's disease: a pilot study. Mov. Disord. 22(7), 946-952 (2007). •• An uncontrolled 15-patient pilot study that explored the feasibility of using CBT to treat dPD. Patients experienced significant reductions in depressed mood and negative cognitions over the course of 10-14 weeks of treatment, providing preliminary evidence as to the effectiveness of this approach.
53. Cole K, Vaughan FL. Brief cognitive-behavioral therapy for depression associated with Parkinson's disease: a single case series. Behav. Cogn Psychother. 33, 89-102 (2005).
54. Feeney F, Egan S, Gasson N. Treatment of depression and anxiety in Parkinson's disease: a pilot study using group cognitive behavioural therapy. Clin. Psychol. 9(1), 31-38 (2005).
55. Simons G, Thompson BN, Pasqualini MCS. An innovative programme for people with Parkinson's disease and their carers. Parkinsonism Relat. Disord. 12, 478-485 (2006).
56. Jamison PM, Welsh M, Corser C, Simmons WJ, Enguidanos SM. Results of a psychosocial needs assessment of people with PD. Mov. Disord. 21(S13), S158 (2006). •• Presents the results of a psychosocial needs assessment conducted amongst PD patients. Results indicated that they desire additional nonpharmacological approaches to be developed to help them cope with their medical condition.
57. Posen J, Gilaldi N. Social work at the crossroads of Parkinson's disease. Mov. Disord. 21(S13), S158 (2006).
58. Azuma T, Cruz RF, Bayles KA, Tomoeda CK, Montgomery EB. A longitudinal study of neuropsychological change in individuals with Parkinson's disease. Int. J. Geriatr. Psychiatry 18, 1115-1120 (2003).
59. Troster AI, Stalp LD, Paolo AM, Fields JA, Koller WC. Neuropsychological impairment in Parkinson's disease with and without depression. Arch. Neurol. 52(12), 1164-1169 (1995).
60. Kuzis G, Sabe L, Tiberti C, Leiguarda R, Starkstein SE. Cognitive functions in major depression and Parkinson's disease. Arch. Neurol. 54(8), 982-986 (1997).
61. Norman S, Troster AI, Fields JA, Brooks R. Effects of depression and Parkinson's disease on cognitive functioning. J. Neuropsychiatr. Clin. Neurosci. 14, 31-36 (2002).
62. Troster AI, Paolo AM, Lyons KE, Glatt, SL, Huble JP, Koller WC. The influence of depression on cognition in Parkinson's disease: a pattern of impairment distinguishable from Alzheimer's disease. Neurology 45, 672-676 (1995).
63. Simpson SW, Baldwin RC, Burns A, Jackson A. Regional cerebral volume measurements in late-life depression: relationship to clinical correlates, neuropsychological impairment, and response to treatment. Int. J. Geriatr. Psychiatry 16, 469-476 (2001).
64. Alexopoulos GS, Kiosses DN, Choi SJ, Murphy CF, Lim KO. Frontal white matter microstructure and treatment response to late-life depression: a preliminary study. Am. J. Psychiatry 159(11), 1929-1932 (2002).
65. Dunkin JJ, Leuchter AF, Cook IA, Kasl-Godley JE, Abrams M, Rosenberg-Thompson S. Executive dysfunction predicts nonresponse to fluoxetine in major depression. J. Affect. Dis. 60, 13-23 (2000).
66. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive Therapy of Depression. Guilford, NY, USA (1979). •• A seminal volume that presents the theory and rationale for CBT approach.
67. Goldapple K, Segal Z, Garson C et al. Modulation of cortical-limbic pathways in major depression: treatment specific effects of cognitive behavior therapy. Arch. Gen. Psychiatry 61(1), 34-41 (2004).
68. Cole K, Vaughan FL. The feasibility of using cognitive behavior therapy for depression associated with Parkinson's disease: a literature review. Parkinsonism Relat. Disord. 11, 269-276 (2005).
69. Mohlman J, Gorman JM. The role of executive functioning in CBT: a pilot study with anxious older adults. Behav. Res. Ther. 43(4), 447-465 (2005).
70. Menza MA, Rosen R. Sleep in Parkinson's disease: the role of depression and anxiety. Psychosomatics 36, 262-266 (1995).
71. Menza MA, Robertson-Hoffmann DE, Bonapace AS. Parkinson's disease and anxiety: comorbidity with depression. Biol. Psychiatry 34, 465-470 (1993).
72. Henderson R, Kurlan R, Kersun JM, Como P. Preliminary examination of the comorbidity of anxiety and depression in Parkinson's disease. J. Neuropsychiatr. Clin. Neurosci. 4, 257-264 (1992).
73. Schiffer RB, Kurlan R, Rubin A et al. Evidence of atypical depression in Parkinson's disease. Am. J. Psychiatry 145, 1020-1022 (1988).
74. Brooks DJ, Doder M. Depression in Parkinson's disease. Curr. Opin. Neurol. 14(4), 465-470 (2001).
75. Chrischilles EA, Rubenstein LM, Voelker MD, Wallace RB, Rodnitzky RL. Linking clinical variables to health-related quality of life in Parkinson's disease. Parkinsonism Relat. Disord. 8, 199-209 (2002).
76. Shulman LM, Taback RL, Bean J, Weiner WJ. Comorbidity of the nonmotor symptoms of Parkinson's disease. Mov. Disord. 16(3), 507-510 (2002).
77. Cohen S, Wills TA. Stress, social support, and the buffering hypothesis. Psychol. Bull. 98(2), 310-357 (1985).
78. Coyne JC. Toward an interactional description of depression. Psychiatry 39, 28-40 (1976).
79. Coyne JC, Delongis A. Going beyond support: the role of social relationships in adaptation. J. Consult. Clin. Psychol. 54(4), 454-460 (1986).
80. Aarsland D, Larsen JP, Karlsen K, Lim NG, Tandberg E. Mental symptoms in Parkinson's disease are important contributors to caregiver distress. Int. J. Geriatr. Psychiatry 14(10), 866-874 (1999).
81. Tommessen B, Aarsland D, Braekhus A et al. The psychosocial burden on spouses of the elderly with stroke, dementia, and Parkinson's disease. Int. J. Geriatr. Psychiatry 17(1), 78-84 (2002).
82. Greene SM, Griffin WA. Symptom study in context: effects of marital quality on signs of Parkinson's disease during patient-spouse interaction. Psychiatry 61(1), 35-45 (1998).
83. Scheurs KMG, DeRidder DTD, Bensing JM. A one-year study of coping, social support, and quality of life in Parkinson's disease. Psychol. Health 15, 109-121 (2000).
84. Edwards NE, Scheetz PS. Predictors of burden for caregivers of patients with Parkinson's disease. J. Neurosci. Nurs. 34(4), 184-190 (2002).
85. Ehmann TS, Beninger RJ, Gawel MJ, Riopelle RJ. Coping, social support, and depressive symptoms in Parkinson's disease. J. Geriatr. Psychiatry Neurol. 3(2), 85-90 (1990).
86. MacCarthy B, Brown R. Psychosocial factors in Parkinson's disease. Br. J. Clin. Psychol. 28, 41-52 (1989).
87. Speer DC. Predicting Parkinson's disease patient and caregiver adjustment: preliminary findings. Behav. Health Aging 3, 139-146 (1993).
88. Fleminger S. Left sided Parkinson's disease is associated with greater anxiety and depression. Psychol. Med. 21, 629-638 (1991).
89. Dobkin RD, Panzarella C, Fernandez J, Alloy LB, Cascardi M. Adaptive inferential feedback, depressogenic inferences, and depressed mood: a laboratory study of the expanded hopelessness theory of depression. Cogn Ther. Res. 28(4), 487-509 (2004).
90. Alloy LB, Abramson LY, Tashman NA et al. Developmental origins of cognitive vulnerability to depression: parenting, cognitive, and inferential feedback styles of the parents of individuals at high and low cognitive risk for depression. Cogn Ther. Res. 25 (4), 397-423 (2001).
91. Lewinsohn PM, Munoz RF, Youngren MA, Zeiss AM. Control Over Depression (2nd Edition). Prentice Hall, Englewood Cliffs, NJ, USA (1986).
92. Leahy RL, Holland SJ. Treatment Plans and Interventions for Depression and Anxiety Disorders. Guilford Publications, NY, USA (2000).
93. Classic symptoms of Parkinson's disease may not be most disabling. Parkinson's Community News www.pdf.org